Document is current
Any future updates will be listed below
-
Authors
Tanaka, Yoshiya
Kodama, Yuzo
Nakayamada, Shingo
Masamune, Atsushi
Sato, Hirokazu https://orcid.org/0009-0009-6070-584X
Takahashi, Akiko
Shibata, Junichiro
Takeshima, Yusuke
Kawano, Mitsuhiro
-
Funding
Funding for this research was provided by:
Tanabe Pharma Corporation
- License Information
-
More Information
Article History
Received: 31 March 2026
Accepted: 5 June 2026
First Online: 22 June 2026
Declarations
:
: Yoshiya Tanaka reports receiving speaking fees and/or honoraria from Chugai Pharmaceutical Co., Ltd., UCB, AbbVie, AstraZeneca, Eli Lilly, Boehringer Ingelheim, GlaxoSmithKline, Eisai, IQVIA, Daiichi-Sankyo, Otsuka Pharmaceutical, Taisho Pharmaceutical, Gilead Sciences, and Bristol Myers Squibb. Yoshiya Tanaka is an Editorial Board member of Rheumatology and Therapy ; Yoshiya Tanaka was not involved in the selection of peer reviewers for the manuscript, nor any of the subsequent editorial decisions. Yuzo Kodama reports receiving speaking fees and/or honoraria from Tanabe Pharma Corporation. Shingo Nakayamada reports receiving speaking fees and/or honoraria from GlaxoSmithKline, Eli Lilly, Asahi Kasei, Bristol Myers Squibb, Otsuka Pharmaceutical, Eisai, AstraZeneca, AbbVie, Astellas Pharma, Tanabe Pharma, Janssen, Chugai Pharmaceutical, Taisho Pharmaceutical, Ayumi Pharmaceutical, Gilead Sciences, UCB, Pfizer, and Boehringer Ingelheim. Atsushi Masamune reports receiving speaking fees and/or honoraria from Tanabe Pharma Corporation. Hirokazu Sato and Akiko Takahashi are employees of Tanabe Pharma Corporation. Junichiro Shibata is a researcher at TXP Medical Co., Ltd. Yusuke Takeshima has a service contract with TXP Medical Co., Ltd. for medical data analysis. Mitsuhiro Kawano reports receiving speaking fees and/or honoraria from Tanabe Pharma Corporation.
: The study protocol was approved by the Non-Profit Organization MINS Institutional Review Board (IRB ID 12000060) and, where required, by the institutional ethics committees of each participating site. A complete list of all ethics committees and their reference numbers is provided in Supplemental Material . The study is conducted in accordance with the Declaration of Helsinki and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects (Japan). Written informed consent will be obtained from all participants prior to enrollment. The study is registered with the Japan Registry of Clinical Trials (jRCT1031250749 [ ]).
